CLINICAL EFFECTIVENESS OF ABATACEPT MONOTHERAPY OR ABATACEPT CONCOMITANT METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (BDMARDS)

dc.conference.dateJUN 03, 2020
dc.conference.titleAnnual European Congress of Rheumatology (EULAR)
dc.contributor.authorMarquez Pete, N.
dc.contributor.authorMaldonado Montoro, M. D. M.
dc.contributor.authorPerez Ramirez, C.
dc.contributor.authorCaliz Caliz, R.
dc.contributor.authorJimenez Morales, A.
dc.contributor.authoraffiliation[Marquez Pete, N.] Virgen Nieves Univ Hosp, Pharm Serv, Pharmacogenet Unit, Granada, Spain
dc.contributor.authoraffiliation[Marquez Pete, N.] Univ Granada, Granada, Spain
dc.contributor.authoraffiliation[Maldonado Montoro, M. D. M.] Clin San Cecilio Univ Hosp, Clin Anal Serv, Granada, Spain
dc.contributor.authoraffiliation[Perez Ramirez, C.] Virgen Macarena Univ Hosp, Pharmacogenet Unit, Pharm Serv, Seville, Spain
dc.contributor.authoraffiliation[Caliz Caliz, R.] Virgen Nieves Univ Hosp, Rheumatol Serv, Granada, Spain
dc.contributor.authoraffiliation[Jimenez Morales, A.] Virgen Nieves Univ Hosp, Pharm Serv, Granada, Spain
dc.date.accessioned2025-01-07T14:13:16Z
dc.date.available2025-01-07T14:13:16Z
dc.date.issued2020-06-01
dc.identifier.doi10.1136/annrheumdis-2020-eular.6047
dc.identifier.essn1468-2060
dc.identifier.issn0003-4967
dc.identifier.unpaywallURLhttps://ard.bmj.com/content/annrheumdis/79/Suppl_1/1440.2.full.pdf
dc.identifier.urihttps://hdl.handle.net/10668/26224
dc.identifier.wosID555905004515
dc.issue.number1
dc.journal.titleAnnals of the rheumatic diseases
dc.journal.titleabbreviationAnn. rheum. dis.
dc.language.isoen
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen de las Nieves
dc.organizationSAS - Hospital Universitario San Cecilio
dc.organizationSAS - Hospital Universitario Virgen Macarena
dc.page.number1436-1436
dc.publisherBmj publishing group
dc.rights.accessRightsopen access
dc.titleCLINICAL EFFECTIVENESS OF ABATACEPT MONOTHERAPY OR ABATACEPT CONCOMITANT METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS PATIENTS PREVIOUSLY TREATED WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (BDMARDS)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number79
dc.wostypeMeeting Abstract

Files